NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Total Liabilities (2010 - 2026)

NextPlat's (NXPL) quarterly Total Liabilities came in at $12.2 million in Q2 2026, up 64.13% year-over-year from $7.4 million in Q2 2025, and up 17.82% quarter-over-quarter from $10.3 million in Q1 2026.

Analysis

NextPlat (NXPL) Total Liabilities (2010 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Total Liabilities for 17 consecutive years, with $12.2 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Total Liabilities rose 64.13% year-over-year to $12.2 million in Q2 2026; TTM through Jun 2026 was $12.2 million, a 64.13% increase from a year earlier, with the FY2025 full-year figure at $10.0 million, up 3.75% from the prior year.
  • Total Liabilities was $12.2 million for Q2 2026 at NextPlat, up from $10.3 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $18.0 million in Q1 2024 and troughed at $1.9 million in Q1 2022.
  • A 5-year average of $8.9 million and a median of $9.7 million in 2024 frame the typical range for Total Liabilities.
  • Across the five-year window, Total Liabilities surged 611.14% in 2023 and slumped 48.75% in 2025, its largest moves.
  • Over 5 years, Total Liabilities stood at $2.9 million in 2022, then surged by 471.2% to $16.4 million in 2023, then tumbled by 40.91% to $9.7 million in 2024, then climbed by 3.75% to $10.0 million in 2025, then increased by 21.35% to $12.2 million in 2026.
  • The last three Total Liabilities figures came in at $12.2 million (Q2 2026), $10.3 million (Q1 2026), and $10.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 32.10 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 20.78 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 1.99 Bn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 3.74 Bn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 25.60 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 896.90 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn 1.78 Bn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 975.61 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 33.31 Mn
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn 12.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.19 Mn
Mar 31, 2026 10.34 Mn
Dec 31, 2025 10.04 Mn
Sep 30, 2025 8.47 Mn
Jun 30, 2025 7.43 Mn
Mar 31, 2025 9.75 Mn
Dec 31, 2024 9.68 Mn
Sep 30, 2024 11.31 Mn
Jun 30, 2024 14.49 Mn
Mar 31, 2024 17.97 Mn
Dec 31, 2023 16.38 Mn
Sep 30, 2023 16.66 Mn
Jun 30, 2023 2.49 Mn
Mar 31, 2023 3.09 Mn
Dec 31, 2022 2.87 Mn
Sep 30, 2022 2.34 Mn
Jun 30, 2022 2.39 Mn
Mar 31, 2022 1.93 Mn
Dec 31, 2021 3.03 Mn
Sep 30, 2021 1.51 Mn